Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julius Popp

Showing results (81-90 of 156) with videos related to

Pageof 16
Sort By:
Alzheimer'S Research & Therapy|July 25, 2024
Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progressionMiriam Rabl, Leonardo Zullo, Piotr Lewczuk, et al.
Neurology|January 1, 2017
Sleep characteristics and cognitive impairment in the general population: The HypnoLaus studyJosé Haba-Rubio, Helena Marti-Soler, Nadia Tobback, et al.
Journal of Alzheimer'S Disease : JAD|August 16, 2011
Association of N-acetylaspartate and cerebrospinal fluid Aβ42 in dementiaFrank Jessen, Piotr Lewczuk, Okan Gür, et al.
Revue Medicale Suisse|September 28, 2022
[Recommendations for the prevention, diagnosis, and therapy of addiction in the elderly]Julius Popp, Andreas Fuchs, Ulrich Hemmeter, et al.
Neurology|August 24, 2012
Glucose metabolism, gray matter structure, and memory decline in subjective memory impairmentLukas Scheef, Annika Spottke, Moritz Daerr, et al.
Neurobiology of Aging|December 2, 2014
Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's typeJulius Popp, Steffen Wolfsgruber, Isabella Heuser, et al.
Praxis|January 29, 2014
[Recommendations for diagnosis and therapy of behavioral and psychological symptoms in dementia (BPSD)]Egemen Savaskan, Irene Bopp-Kistler, Markus Buerge, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 26, 2015
CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter studyMichael Ewers, Niklas Mattsson, Lennart Minthon, et al.
Frontiers in Aging Neuroscience|August 9, 2021
Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own StudiesLiu Shi, Noel J Buckley, Isabelle Bos, et al.
Praxis|December 19, 2024
[Alzheimer's disease - system prepardeness in the context of new developments]Rafael Meyer, Andreas Monsch, Gilles Allali, et al.
Pageof 16

Showing results (81-90 of 156) with videos related to

Sort By:
Pageof 16
Alzheimer'S Research & Therapy|July 25, 2024
Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progressionMiriam Rabl, Leonardo Zullo, Piotr Lewczuk, et al.
Neurology|January 1, 2017
Sleep characteristics and cognitive impairment in the general population: The HypnoLaus studyJosé Haba-Rubio, Helena Marti-Soler, Nadia Tobback, et al.
Journal of Alzheimer'S Disease : JAD|August 16, 2011
Association of N-acetylaspartate and cerebrospinal fluid Aβ42 in dementiaFrank Jessen, Piotr Lewczuk, Okan Gür, et al.
Revue Medicale Suisse|September 28, 2022
[Recommendations for the prevention, diagnosis, and therapy of addiction in the elderly]Julius Popp, Andreas Fuchs, Ulrich Hemmeter, et al.
Neurology|August 24, 2012
Glucose metabolism, gray matter structure, and memory decline in subjective memory impairmentLukas Scheef, Annika Spottke, Moritz Daerr, et al.
Neurobiology of Aging|December 2, 2014
Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's typeJulius Popp, Steffen Wolfsgruber, Isabella Heuser, et al.
Praxis|January 29, 2014
[Recommendations for diagnosis and therapy of behavioral and psychological symptoms in dementia (BPSD)]Egemen Savaskan, Irene Bopp-Kistler, Markus Buerge, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 26, 2015
CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter studyMichael Ewers, Niklas Mattsson, Lennart Minthon, et al.
Frontiers in Aging Neuroscience|August 9, 2021
Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own StudiesLiu Shi, Noel J Buckley, Isabelle Bos, et al.
Praxis|December 19, 2024
[Alzheimer's disease - system prepardeness in the context of new developments]Rafael Meyer, Andreas Monsch, Gilles Allali, et al.
Pageof 16